Silexion Therapeutics announces 1-for-10 reverse share split to maintain Nasdaq listing

Silexion Therapeutics Corp

Reverse share split at 1:10 ratio; effective after market close May 28, 2026; split-adjusted trading begins May 29, 2026.
Ticker remains SLXN; new CUSIP assigned; par value increases from $0.0135 to $0.135 per share.
No fractional shares issued; DTC participants' fractional shares rounded up to nearest whole share.
Split intended to maintain Nasdaq minimum bid price compliance (Rule 5550(a)(2)) and support equity financings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.